RIO Pharmaceuticals LLC

San Francisco, CA

UEI
KUXQR7CEYG46
CAGE
632H4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
18 Elsie St, San Francisco, CA 94110, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
The Regents Of The University Of California. San Francisco Rio Pharmaceutical Inc. The planned four-year project will occur between August 15, 2022 and May 31, 2026. The University of California, San Francisco (UCSF)… R01AG072743 $880,448

Quick answers

Is RIO Pharmaceuticals LLC registered in SAM.gov?

Yes. RIO Pharmaceuticals LLC's SAM.gov registration is active through May 28, 2027.

What is RIO Pharmaceuticals LLC's most recent federal award?

RIO Pharmaceuticals LLC's most recent federal grant award is Astroglial EAAT2 changes in live TBI brain determined by pet imaging (R41NS105309), from National Institute of Neurological Disorders and Stroke (NIH), on September 1, 2018.

On GovTribe

See RIO Pharmaceuticals LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors